{"id":"NCT03344458","sponsor":"Ascendis Pharma A/S","briefTitle":"A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial","officialTitle":"enliGHten: A Multicenter, Phase 3, Long-Term, Open-Label Trial Investigating Safety and Efficacy of TransCon hGH Administered Once-Weekly in Children With Growth Hormone Deficiency (GHD) Who Have Completed a Prior TransCon hGH Clinical Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-19","primaryCompletion":"2023-02-21","completion":"2023-02-21","firstPosted":"2017-11-17","resultsPosted":"2024-05-08","lastUpdate":"2024-05-08"},"enrollment":298,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Growth Hormone Deficiency, Pediatric","Endocrine System Diseases","Hormone Deficiency","Pituitary Diseases"],"interventions":[{"type":"DRUG","name":"TransCon hGH","otherNames":[]}],"arms":[{"label":"TransCon hGH","type":"EXPERIMENTAL"}],"summary":"A multicenter, phase 3, long-term extension trial of TransCon hGH administered once-weekly in children with growth hormone deficiency (GHD) who previously participated in a phase 3 TransCon hGH trial. Approximately 300 children (males and females) with GHD will be included. All study participants will receive TransCon hGH. This is a global trial that will be conducted in, but not limited to, the United States, Poland, Bulgaria, Ukraine, Armenia, Russia and Australia.","primaryOutcome":{"measure":"Number of Subjects With Treatment-Emergent Adverse Events [Long-Term Safety and Tolerability]","timeFrame":"Up to Week 208","effectByArm":[{"arm":"Lonapegsomatropin","deltaMin":226,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":42,"countries":["United States","Armenia","Australia","Belarus","Bulgaria","Georgia","Greece","New Zealand","Poland","Russia","Ukraine"]},"refs":{"pmids":["35428884"],"seeAlso":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202697/"]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":298},"commonTop":["Upper respiratory tract infection","COVID-19","Nasopharyngitis","Pyrexia","Headache"]}}